|
Pat Scannon is the Company Founder, Executive Vice President, Chief Biotechnology Officer, and a member of the Board of Directors, of XOMA Ltd. Since 1980, Dr. Scannon has directed the Company's product identification, evaluation, and clinical testing programs. As Chief Biotechnology Officer, he heads the clinical and preclinical research programs, evaluating several classes of biologic compounds, and conducting clinical studies for infectious, oncologic, and immunologic indications.Dr. Scannon holds a Ph.D. in organic chemistry from the University of California, Berkeley and a medical degree from the Medical College of Georgia. He completed his medical internship and residency at the Letterman Army Medical Center in San Francisco. A Board-certified internist, Dr. Scannon is also a member of the American College of Physicians. He has served as a Trustee of the University of California Berkeley Foundation and is a member of the University of California Berkeley Chancellor's Community Advisory Board. He has served or is serving on the Boards of several companies and institutions, and is currently a member of the DSRC (Defense Sciences Research Council), an advisory board for DARPA (Defense Advanced Research Projects Agency). Dr. Scannon is inventor or co-inventor of several issued U.S. patents, and he has published numerous scientific abstracts and papers. | 